CPRIT awards Mays Cancer Center more than $10.3 million

August 25, 2020

Mingjiang Xu, MD, PhD, professor of molecular medicine and the San Antonio Cancer Council Distinguished Chair in Oncology, will receive an Individual Investigator Award of $900,000. The topic is “Role of HOTTIP lncRNA in Leukemogenesis.” Dr. Xu is interested in long non-coding RNAs, which if dysregulated play major roles in the development and progression of […]

Enhancer RNAs mediate estrogen-induced decommissioning of selective enhancers by recruiting ERa and its cofactor

May 19, 2020

Abstract: The function of enhancer RNAs (eRNAs) in transcriptional regulation remains obscure. By analyzing the genome-wide nascent transcript profiles in breast cancer cells, we identify a special group of eRNAs that are essential for estrogen-induced transcriptional repression. Using eRNAs of TM4SF1 and EFEMP1 as the paradigms, we find that these RNA molecules not only stabilize […]

A Nature Cell Biology article published by a Molecular Medicine team lead by Dr. Jason Liu, reveals a coordinated function for GATA3 and AP1 in altering enhancer landscapes, thereby promoting a basal/mesenchymal phenotype and endocrine resistance in breast cancer.

May 18, 2020

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance   Abstract: Acquired therapy resistance is a major problem for anticancer treatment, yet the underlying molecular mechanisms remain unclear. Using an established breast cancer cellular model, we show that endocrine resistance is associated with enhanced phenotypic plasticity, indicated […]

Nomination for the 2019 Cancer Center Discovery of the Year – Congratulations to Dr. Jason Liu

February 28, 2020

Dr. Jason Liu has been nominated for the Mays Cancer Center 2019 Discovery of the Year Award for his publication, A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer, in Molecular Cell. Abstract: YAP and TEAD are nuclear effectors of the Hippo signaling pathway that regulates organ size and […]

2020 Presidential Awards – Congratulations to Dr. Renee Yew

February 28, 2020

Dr. Renee Yew has been selected to receive a 2020 UT Health Presidential Award in the category of Sustained Excellence in Teaching.  Dr. Yew currently teaches genetics to graduate, medical, and dental students, as well as cell division to graduate students. The 2020 award winners will be honored on Thursday, March 5th.

Acarbose improved survival for Apc+/Min mice

February 20, 2020

Abstract: Acarbose blocks the digestion of complex carbohydrates, and the NIA Intervention Testing Program (ITP) found that it improved survival when fed to mice. Yet, we do not know if lifespan extension was caused by its effect on metabolism with regard to the soma or cancer suppression. Cancer caused death for ~80% of ITP mice. […]

Age-dependent autophagy induction after injury promotes axon regeneration by limiting NOTCH.

January 23, 2020

Abstract: Macroautophagy/autophagy is essential for maintaining cellular homeostasis through the degradation of organelles and proteins. It also has a prominent role in modulating aging. However, the role of autophagy in the neuronal response to axon injury and axon regeneration, particularly in the context of aging, remains largely unknown. Our candidate genetic screen for axon regeneration […]

A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.

January 23, 2020

Abstract: YAP/TEAD are nuclear effectors of the Hippo pathway, regulating organ size and tumorigenesis largely through promoter-associated function. However, their function as enhancer regulators remains poorly understood. Through an in vivo proximity-dependent labeling (BioID) technique, we identified YAP1 and TEAD4 protein as co-regulators of ERα on enhancers. The binding of YAP1/TEAD4 to ERα-bound enhancers is […]

Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer

January 22, 2020

Abstract: Cytometry by time-of-flight (CyTOF) simultaneously measures multiple cellular proteins at the single-cell level and is used to assess inter- and intra-tumor heterogeneity. This approach may be used to investigate the variability of individual tumor responses to treatments. Herein, we stratified lung tumor subpopulations based on AXL signaling as a potential targeting strategy. Integrative transcriptome […]

CENP-A Ubiquitylation Is Indispensable to Cell Viability

January 22, 2020

Abstract: CENP-A is a centromere-specific histone H3 variant that epigenetically determines centromere identity, but how CENP-A is deposited at the centromere remains obscure. We previously reported that CENP-A K124 ubiquitylation, mediated by the CUL4A-RBX1-COPS8 complex, is essential for CENP-A deposition at the centromere. However, a recent report stated that CENP-A K124R mutants show no defects […]